Early Taxane Switching May Improve PSA Response Rates in Prostate Cancer
Early switching from docetaxel to cabazitaxel or vice versa may lead to improved prostate-specific antigen response rates.
Early switching from docetaxel to cabazitaxel or vice versa may lead to improved prostate-specific antigen response rates.